E-PROOF: E-intervention for Protein Intake and Resistance Training to Optimize Function
E-PROOF:蛋白质摄入和阻力训练的电子干预以优化功能
基本信息
- 批准号:10665172
- 负责人:
- 金额:$ 23.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAccountingAddressAdherenceAgeAgingArthritisBehavior TherapyCOVID-19 pandemicCaloriesCancer InterventionCancer PatientCancer SurvivorCancer SurvivorshipClinicalComprehensive Cancer CenterConsumptionControl GroupsCounselingCoupledDataDevelopmentDietDietary InterventionDietary intakeDietitianEducationEducational InterventionEducational MaterialsElderlyExerciseFatigueGeriatricsGoalsHealthHealth Care CostsHealth PromotionHealth behaviorHeart DiseasesHeart RateImpairmentIncidenceIntakeInterventionKnowledgeLeadLung diseasesMalignant NeoplasmsMissionMuscle ProteinsMuscular AtrophyNutritionalObesityOhioOutcomeOutcome StudyPainParticipantPhysical FunctionPhysical assessmentPopulationPredispositionPrevalenceProcessProtein BiosynthesisProteinsPublic HealthRandomizedRandomized, Controlled TrialsRecommendationRecording of previous eventsResearchRiskRisk ReductionSARS-CoV-2 exposureSamplingScienceScientistSelf EfficacyTestingTraining and EducationUniversitiesWeightWeight maintenance regimenWorkacceptability and feasibilityadherence ratebehavior changecomorbiditycomparison controldesigndietaryeffective interventioneffectiveness evaluationefficacy evaluationexercise interventionexercise regimenexperienceexperimental groupfallsfollow-upfunctional disabilitygood diethealth related quality of lifehigh riskhuman old age (65+)improvedinnovationinsightintervention effectintervention participantsmortalitymultiple chronic conditionsmuscle formmuscle strengthnovelnovel strategiesonline deliverypeerpost interventionpreventprogramsprotein intakerandomized trialrecruitresistance exerciseretention ratesarcopeniasurvivorshipwaist circumference
项目摘要
ABSTRACT
Accounting for more than 60% of cancer survivors, older (≥65 years) cancer survivors, have a 2- to 5-fold risk of
physical function impairment, compared to cancer-free controls. Physical function impairment has multiple
deleterious health effects including poor health-related quality of life (HRQoL), multi-morbidity, increased falls,
and all-cause mortality. One strategy to improve physical function is dietary and resistance training interventions,
which improve muscle strength and mass by stimulating muscle protein synthesis. However, there are no
synchronous, online diet and exercise interventions for older cancer survivors, a group at high risk for functional
limitations. Thus, the E-PROOF (E-intervention for Protein Intake and Resistance Training to Optimize Function)
study will examine the feasibility, acceptability, and preliminary efficacy of a 12-week randomized controlled trial
of an online, tailored nutritional and resistance training education and counseling intervention to improve physical
function and associated health outcomes (muscle strength, HRQoL, self-efficacy, and weight management). We
postulate that, compared to the control group, intervention participants would experience statistically significant,
clinically meaningful improvements in physical function and associated health outcomes following the 12-week
diet and resistance training intervention. To achieve our objective, we will: 1) Determine the feasibility and
acceptability of implementing an online dietary and resistance training intervention among 70 older cancer
survivors; and; 2) Examine the preliminary efficacy of an online dietary and resistance training intervention to
improve physical function and associated outcomes among 70 older cancer survivors who participated in a 12-
week intervention. In this pilot randomized controlled trial, participants will be randomized to one of two groups:
one experimental (online counseling by a registered dietitian and exercise scientist, menus, educational
materials on protein, healthy diet, resistance training) and one control (general survivorship education). We will
examine the intervention effects on physical function, muscle strength, HRQoL, self-efficacy, weight, and waist
circumference during a 12-week period between the experimental and control groups. We will conduct a 3-month
follow-up to assess physical function, muscle strength, and HRQoL. The feasibility of conducting an online diet
and resistance training intervention in older cancer survivors will be determined by the study accrual, retention,
and adherence rates. This study will inform the development of a R01 scale randomized controlled trial to
evaluate the effectiveness of a protein-focused meal delivery program and resistance exercise regimen on risk
for functional impairment and sarcopenia among older cancer survivors. The study goals respond to the NIA and
NCI missions to address the research gaps in older cancer survivors and help them lead longer, healthier lives.
This novel study advances science by promoting independent health behaviors among older cancer survivors,
which can improve health outcomes and provide foundational knowledge to further address this growing problem
on a wider scale through online platforms.
抽象的
占癌症幸存者的 60% 以上,年龄较大(≥65 岁)的癌症幸存者罹患癌症的风险是其 2 至 5 倍
与无癌症对照相比,身体功能受损有多种。
有害的健康影响,包括与健康相关的生活质量 (HRQoL) 较差、多种发病率、跌倒次数增加、
改善身体机能的一项策略是饮食和阻力训练干预,
通过刺激肌肉蛋白质合成来提高肌肉力量和质量,但目前还没有。
对老年癌症幸存者(功能障碍高风险群体)进行同步在线饮食和运动干预
因此,E-PROOF(蛋白质摄入和阻力训练的电子干预以优化功能)。
研究将检验为期 12 周的随机对照试验的可行性、可接受性和初步疗效
在线、定制的营养和阻力训练教育和咨询干预,以改善身体状况
功能和相关的健康结果(肌肉力量、HRQoL、自我效能和体重管理)。
假设与对照组相比,干预参与者将经历统计显着性,
12 周后身体机能和相关健康结果出现具有临床意义的改善
为了实现我们的目标,我们将: 1) 确定可行性和
在 70 名老年癌症患者中实施在线饮食和阻力训练干预的可接受性
幸存者;以及;2) 检查在线饮食和阻力训练干预的初步效果
改善参与 12 项研究的 70 名老年癌症幸存者的身体机能和相关结果
周干预 在这项随机对照试验中,参与者将被随机分为两组:
一项实验(由注册营养师和运动科学家提供的在线咨询、菜单、教育
我们将提供有关蛋白质、健康饮食、抵抗训练的材料)和一项对照(一般生存教育)。
检查干预对身体功能、肌肉力量、HRQoL、自我效能、体重和腰围的影响
我们将在实验组和对照组之间进行为期 3 个月的为期 12 周的周长测量。
后续评估身体机能、肌肉力量和 HRQoL 进行在线饮食的可行性。
老年癌症幸存者的阻力训练干预将取决于研究的累积、保留、
本研究将为 R01 量表随机对照试验的开发提供信息。
评估以蛋白质为重点的膳食计划和阻力运动方案对风险的有效性
该研究的目标是针对老年癌症幸存者的功能障碍和肌肉减少症。
NCI 的使命是解决老年癌症幸存者的研究空白,帮助他们过上更长寿、更健康的生活。
这项新颖的研究通过促进老年癌症幸存者的独立健康行为来推动科学发展,
可以改善健康状况并提供基础知识以进一步解决这一日益严重的问题
通过线上平台进行更广泛的推广。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica L. Krok-Schoen其他文献
Jessica L. Krok-Schoen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
套期会计有效性的研究:实证检验及影响机制
- 批准号:72302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
相似海外基金
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
3/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
- 批准号:
10711001 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
为 MedStar Health 接受肺癌筛查的患者提供烟草治疗:一项随机试验
- 批准号:
10654115 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
Sensitivity to Cannabis Effects and Cue Reactivity as Markers of a Developing Disorder in Adolescents
对大麻效应的敏感性和提示反应性作为青少年发育障碍的标志
- 批准号:
10586397 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
2/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
- 批准号:
10711336 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
Non-invasive biometric screening for cerebrovascular disorders in persons with Down syndrome.
唐氏综合症患者脑血管疾病的无创生物识别筛查。
- 批准号:
10816240 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别: